FDA Investigator Cynthia J Tsui
Cynthia J Tsui has conducted inspections on 5 sites in 1 countries as of 12 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
12 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Cynthia J Tsui:
Althea A Williams,
Anh M Lac,
Arindam Dasgupta, PhD,
Ashar P Parikh,
Carl Lee,
Christine M Parmentier,
Daniel J Roberts,
Diane Cvan Leeuwen,
Dustin R Abaonza,
Humberto Z Gomez,
James A Lane,
Jeffrey M Watson,
Jeffrey W Shrifter, DPM,
Jennifer L Degroot,
Jennifer L Johnson,
Kevin P Foley,
Kim Lthomas Cruse,
Kristin M Abaonza,
Lance Mde Souza, MBA,
LCDR Jennifer H Rhyu,
Linda Linh N Adams,
Linh T Tu,
Linh Tu,
Marie K Kinkade,
Marlo Ianm Alintanahin,
Mary R Hole,
Peter E Baker,
Rebecca T Davis,
Sandra S Saniga,
Scott N Lim,
Sharon K Thoma, PharmD,
Stephanie Barragan,
Thea C Grome,
Walden H Lee
Cynthia J Tsui's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2024 | FDA 483 | CymaBay Therapeutics, Inc. - Form 483, 2024-03-20 |
January, 2024 | FDA 483 | ASEGUA THERAPEUTICS LLC - Form 483, 2024-01-22 |
January, 2024 | FDA 483 | Element Science, Inc. - Form 483, 2024-01-22 |
June, 2024 | FDA 483 | Kristen NooShin Ganjoo, M.D. - Form 483, 2024-06-17 |
April, 2024 | FDA 483 | Aparna Goel Nair, M.D. - Form 483, 2024-04-19 |
August, 2024 | FDA 483 | Bruce E. Silverstein, M.D. - Form 483, 2024-08-09 |
September, 2024 | FDA 483 | Radhamangalam J. Ramamurthi, M.D. - Form 483, 2024-09-20 |
October, 2024 | FDA 483 | Arshad M. Khanani, MD - Form 483, 2024-10-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more